Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TLR7 | Q9NYK1 | 12/20 | 0.44 |
| ▸ | MGLL | Q99685 | 2/20 | 0.43 |
| ▸ | CNR2 | P34972 | 2/20 | 0.39 |
| ▸ | CNR1 | P21554 | 1/20 | 0.39 |
| ▸ | CRHR1 | P34998 | 2/20 | 0.37 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.37 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.37 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.37 |
| ▸ | POLB | P06746 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6204471 | 0.91 | TLR7 (0.42) | TLR7TLR8HDAC3HDAC2 | |
| SCHEMBL6205743 | 0.90 | TLR7 (0.41) | TLR7HDAC3HDAC2 | |
| SCHEMBL6203376 | 0.89 | TLR7 (0.39) | TLR7CRHR1TLR8HDAC3HDAC2 | |
| SCHEMBL6203648 | 0.87 | TLR7 (0.40) | TLR7 | |
| SCHEMBL6200464 | 0.86 | TLR7 (0.42) | TLR7CRHR1TLR8POLB | |
| SCHEMBL7476643 | 0.85 | CRHR1 (0.44) | TLR7CRHR1TLR8POLB | |
| SCHEMBL7478618 | 0.83 | CRHR1 (0.42) | TLR7CNR2CRHR1TLR8POLB | |
| SCHEMBL6201435 | 0.83 | CRHR1 (0.41) | TLR7CRHR1TLR8POLB | |
| SCHEMBL6203100 | 0.83 | CRHR1 (0.40) | TLR7CRHR1TLR8 | |
| SCHEMBL5441720 | 0.81 | CRHR1 (0.55) | CNR2CRHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1554258-A1 | 5-SUBSTITUTED-2-ARYLPYRAZINES AS MODULATORS OF CRF RECEPTORS | NEUROGEN CORPORATION (US) | 2005-07-20 | — | — | EP | claimed |
| WO-2004018437-A1 | 5-SUBSTITUTED-2-ARYLPYRAZINES AS MODULATORS OF CRF RECEPTORS | NEUROGEN CORPORATION (US) | 2004-03-04 | — | — | WO | claimed |